Participants in the study will have four study visits over a period of two years (one prior to procedure and 3 post their procedure). Study visits will be conducted via telephone by a third-party CRO and independent clinical research coordinators. Participants will be verbally consented and then evaluated via telephonic study visits at baseline (prior to procedure) and at 3, 12, and 24 months post their intraosseous basivertebral nerve ablation procedure.~Primary and secondary objectives are based on patient reported outcomes for functional improvement, pain reduction, and physical and mental health pre and post procedure. The study will also look at utilization of injections and pain interventions/surgery for treatment of low back pain post Intracept.
This is an independent prospective, noninterventional, observational post market data collection of the patient-reported effectiveness, ongoing safety, and satisfaction outcomes for patients treated with the Intracept Procedure at a single study site.~This study will be conducted according to Good Clinical Practice (GCP) guidelines, including participant verbal informed consent and Independent Review Board (IRB) / Ethics Committee (EC) approval and oversight.~Study design, conduct, analysis, and reporting are overseen by the Principal Investigator (PI) and the cross-specialty Independent Physician Steering Committee.